| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Something More To Targeted Genetics?
Posted on 03/30/2007 17:42:25 | Link | Post Comment
by Jon C. Ogg
24/7 Wall St.
Targeted Genetics (TGEN) is doing something unbelievable today. The company posted actual earning this morning when it was supposed to lose money according the entire large coverage universe of one single analyst. The company posted $0.08 EPS on income of $808,000 on roughly $4 million in revenues. Shares closed yesterday at $2.57, opened just north of $3.00, and shares are now over $4.00 on 16+ million shares.
On last look TGEN was up at $4.35 on 16 million shares and its 52-week trading range is $1.71 to $7.16. Just 4 years ago this was a $20+ stock, so with a springloaded earnings like this it isn't as surprising as it would be on other days. Its market cap After this run is a mere $47 million. This company is so small that it almost never gets mentioned any longer.
Source: 247WallSt.com
RELATED READING:
- Why Doesn't Biogen Idec Just Buyout Target Genetics?
- Targeted Genetics Jumps 52% with No News!
____________________
24/7 Wall St.
Targeted Genetics (TGEN) is doing something unbelievable today. The company posted actual earning this morning when it was supposed to lose money according the entire large coverage universe of one single analyst. The company posted $0.08 EPS on income of $808,000 on roughly $4 million in revenues. Shares closed yesterday at $2.57, opened just north of $3.00, and shares are now over $4.00 on 16+ million shares.
On last look TGEN was up at $4.35 on 16 million shares and its 52-week trading range is $1.71 to $7.16. Just 4 years ago this was a $20+ stock, so with a springloaded earnings like this it isn't as surprising as it would be on other days. Its market cap After this run is a mere $47 million. This company is so small that it almost never gets mentioned any longer.
Source: 247WallSt.com
RELATED READING:
- Why Doesn't Biogen Idec Just Buyout Target Genetics?
- Targeted Genetics Jumps 52% with No News!
____________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
Examples
ATM Wallstreet - Tue Jul 08, 2008 02:28PM
Why I traded the stock ME today. I had it on my list fr [read more]
Why I traded the stock ME today. I had it on my list fr [read more]
Morpheus Trading - Thu Jul 03, 2008 07:49AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Sun Jul 06, 2008 11:00PM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
<< My Home | TheMoneyBlogs Home